As the chart shows, Rigetti's sales multiple is more than six times IonQ's, suggesting the latter is the better value. This, ...
Cancellations now stem from clinical failures rather than funding shortages, signaling a healthier market for contract ...
Production ramps create near-term cost pressure, but management sees a clear path to 18% operating margins by decade's end.
Tesla (TSLA-3.08%) reported third-quarter results late Wednesday, Oct. 21, and the stock has inched lower since. Shares trade ...
Pricing power and operational discipline held margins steady even as sales flatlined, signaling resilience beyond the current ...
Higher charge-offs and lower earnings guidance offset the strategic wins from new funding partnerships and loan retention.
Two of these creatures are Pfizer ( PFE +1.91%) and AbbVie ( ABBV +0.14%). But in an environment of rising interest rates, ...
Kimberly-Clark operates as a global leader in personal care and hygiene, manufacturing essential products like Huggies ...
A recent survey shows reasons to be bullish on international stocks. But some global ETFs look more bullish than others.
Pfizer's revenue swung sharply lower before stabilizing, while Bristol Myers Squibb kept climbing steadily—a divergence that ...
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct ...
Gross margins hit 64% as industrial and data center demand converged, but capital spending is climbing to nearly $3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results